339 related articles for article (PubMed ID: 8772810)
1. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
Varma N; Varma S; Marwaha N; Garewal G
Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
[TBL] [Abstract][Full Text] [Related]
2. [Aplastic anemia and myelodysplasia: a not-always-easy distinction].
Sardeo G; Gaion F; Artusi T; Dalla Pria AF; Romano G; Puglisi A
Minerva Med; 1987 Oct; 78(20):1519-22. PubMed ID: 3670695
[TBL] [Abstract][Full Text] [Related]
3. [A study of hypoplastic myelodysplastic syndrome].
Sato Y; Mituhashi S; Otani K; Kamoshita M; Hasegawa Y; Ninomiya H; Nagasawa T; Abe T
Rinsho Ketsueki; 1993 Nov; 34(11):1431-7. PubMed ID: 8254904
[TBL] [Abstract][Full Text] [Related]
4. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of femoral marrow cellularity in hypocellular haemopoietic disorders.
Lorand-Metze I; Santiago GF; Lima CS; Zanardi VA; Torriani M
Clin Radiol; 2001 Feb; 56(2):107-10. PubMed ID: 11222066
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
7. The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia.
Lorand-Metze I; Meira DG; Lima CS; Vassallo J; Metze K
Haematologica; 1999 Jun; 84(6):564-5. PubMed ID: 10366807
[No Abstract] [Full Text] [Related]
8. [Differential diagnosis between aplastic anemia and hypoplastic myelodysplastic syndromes: from the viewpoint of pediatrics].
Hama A; Ito M; Kojima S
Rinsho Ketsueki; 2012 Oct; 53(10):1485-91. PubMed ID: 23037720
[No Abstract] [Full Text] [Related]
9. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance imaging of the bone marrow in patients with aplastic anemia and myelodysplastic syndrome].
Kusumoto S
Rinsho Ketsueki; 1992 Apr; 33(4):423-9. PubMed ID: 1602604
[TBL] [Abstract][Full Text] [Related]
11. Significance of electron-dense deposits in the mitochondrial matrix of erythroid precursors in aplastic anaemia and myelodysplastic syndrome.
Bessho F; Ohnishi H; Tabuchi K; Kobayashi M; Hayashi Y
Br J Haematol; 1999 Apr; 105(1):149-54. PubMed ID: 10233378
[TBL] [Abstract][Full Text] [Related]
12. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
13. [Histopathologic characteristics of bone marrow in patients with aplastic anemia].
Milosević R; Janković G; Antonijević N; Jovanović V; Babić D; Colović M
Srp Arh Celok Lek; 2000; 128(5-6):200-4. PubMed ID: 11089422
[TBL] [Abstract][Full Text] [Related]
14. Quantification of marrow CD34+ cells: An important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia.
Orazi A
Leukemia; 2006 Nov; 20(11):2041; author reply 2041-2. PubMed ID: 16990766
[No Abstract] [Full Text] [Related]
15. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.
Aalbers AM; van den Heuvel-Eibrink MM; Baumann I; Dworzak M; Hasle H; Locatelli F; De Moerloose B; Schmugge M; Mejstrikova E; Nováková M; Zecca M; Zwaan CM; Te Marvelde JG; Langerak AW; van Dongen JJ; Pieters R; Niemeyer CM; van der Velden VH
Haematologica; 2015 Mar; 100(3):315-23. PubMed ID: 25425683
[TBL] [Abstract][Full Text] [Related]
16. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
17. CD34 and p53 immunohistochemical stains differentiate hypocellular myelodysplastic syndrome (hMDS) from aplastic anemia and a CD34 immunohistochemical stain provides useful survival information for hMDS.
Cha CH; Park CJ; Chi HS; Seo EJ; Jang S; Cho YU; Lee KH; Lee JH; Lee JH; Im HJ; Seo JJ
Ann Lab Med; 2014 Nov; 34(6):426-32. PubMed ID: 25368817
[TBL] [Abstract][Full Text] [Related]
18. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.
Yue G; Hao S; Fadare O; Baker S; Pozdnyakova O; Galili N; Woda BA; Raza A; Wang SA
Leuk Res; 2008 Apr; 32(4):553-8. PubMed ID: 17888511
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow histological changes in myelodysplastic syndrome and its clinical significance].
Liu XF; Wang BM; Yi FH
Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):675-7, 729. PubMed ID: 1815870
[TBL] [Abstract][Full Text] [Related]
20. [Survey on examinations for diagnosis of bone marrow failure in Japan: a report from the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes].
Araseki K; Matsuda A; Tohyama K; Ishikawa T; Kawabata H; Miyazaki Y; Nakao S; Tomonaga M; Takaori-Kondo A; Kurokawa M; Omine M; Ozawa K
Rinsho Ketsueki; 2012 Jul; 53(7):691-7. PubMed ID: 22975771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]